Rocket Pharmaceuticals, Inc. (RCKT)
$2.21-3.91%Close
SELLCRISIS · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $241M
- Beta
- 0.50
- P/E (TTM)
- -13.81
- Short % float
- 17.31%
- Days to cover
- 6.9
- SI change
- +1.4%
- 1W
- -12.99%
- 1M
- -35.19%
- vs SPY 1W
- -12.01%
- vs SPY 1M
- -37.06%
Industry peers
FMP comparable companies · ranked by market cap
- LBRXSELLLB Pharmaceuticals Inc Common Stock$1.1BCRISISQ 73$37.22-2.27%
- DSGNSELLDesign Therapeutics, Inc.$728MCRISISQ -14$11.65-0.51%
- AURASELLAura Biosciences, Inc.$676MRECOVERYQ -6$6.54-1.59%
- SLDBSELLSolid Biosciences Inc.$676MCRISISQ -14$6.87-6.01%
- ANNXSELLAnnexon, Inc.$659MCRISISQ -9$4.02-4.18%
- IMABI-Mab$542M$2.88
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS & VALIDATION
[SCORES & PROFILE]
- FUND
- 17
- VALUE
- 20
- GROWTH
- 47
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-3.5%
REV YoY-
ROE-5.8%
EPS YoY-
ROA-4.1%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-13.81
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B0.68
P/FCF-
EV/EBITDA7.17
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E6.72
ALTMAN Z-
CURR RATIO9.24
ND/EBITDA-
BETA0.50
[BEST COMBO]VALIDATED · V5
ENTER · HOLD · EXIT · WAITOne next-open action from five signal families, published only when the held-out edge survives 20 bps costs.
Today's action with its out-of-fold profit factor, trade count and family votes.
[WHITE ARROW]FULL HISTORY
SELL
Directional consensus stays BUY or SELL until the model reverses; trades fill next session open.
PROFIT FACTOR1.1
TRADES54
[REGIME]FULL HISTORY
CRISIS
BULL or RECOVERY stays invested; BEAR or CRISIS exits at the next session open.
Profit factor and trade count for holding this symbol only in BULL or RECOVERY.
[EXHAUSTION]NOW
Whether buyers or sellers are stretched today, the latest release and its strength.
Company news
FAQ
- What is LOPJLB’s current signal on RCKT?
- LOPJLB’s latest quantitative signal on Rocket Pharmaceuticals, Inc. (RCKT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RCKT in?
- Rocket Pharmaceuticals, Inc. (RCKT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Rocket Pharmaceuticals, Inc. (RCKT) do?
- Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs. It is currently progressing three ex vivo lentiviral vector therapies aimed at specific genetic conditions: Fanconi anemia, char…